S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
NFLX   293.35 (+2.47%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
NFLX   293.35 (+2.47%)
Log in

Stryker Stock Price, News & Analysis (NYSE:SYK)

$215.82
+0.07 (+0.03 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$215.02
Now: $215.82
$217.00
50-Day Range
$207.76
MA: $216.82
$222.05
52-Week Range
$144.75
Now: $215.82
$223.45
Volume38,935 shs
Average Volume1.15 million shs
Market Capitalization$80.74 billion
P/E Ratio29.60
Dividend Yield0.98%
Beta0.81
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.60 billion
Cash Flow$9.50 per share
Book Value$31.35 per share

Profitability

Net Income$3.55 billion

Miscellaneous

Employees36,000
Market Cap$80.74 billion
Next Earnings Date10/29/2019 (Confirmed)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Stryker (NYSE:SYK) Frequently Asked Questions

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Wednesday, July 31st. Shareholders of record on Monday, September 30th will be paid a dividend of $0.52 per share on Thursday, October 31st. This represents a $2.08 annualized dividend and a yield of 0.96%. The ex-dividend date is Friday, September 27th. View Stryker's Dividend History.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its quarterly earnings results on Thursday, July, 25th. The medical technology company reported $1.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.05. The medical technology company had revenue of $3.65 billion for the quarter, compared to the consensus estimate of $3.60 billion. Stryker had a return on equity of 25.98% and a net margin of 24.99%. The company's quarterly revenue was up 9.9% compared to the same quarter last year. During the same period last year, the company earned $1.76 EPS. View Stryker's Earnings History.

When is Stryker's next earnings date?

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Stryker.

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $8.15-8.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.15.

What price target have analysts set for SYK?

22 analysts have issued 12 month price targets for Stryker's shares. Their forecasts range from $156.75 to $240.00. On average, they anticipate Stryker's stock price to reach $214.39 in the next twelve months. This suggests that the stock has a possible downside of 0.8%. View Analyst Price Targets for Stryker.

What is the consensus analysts' recommendation for Stryker?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 5 hold ratings and 17 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

Has Stryker been receiving favorable news coverage?

Media headlines about SYK stock have trended somewhat positive this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stryker earned a daily sentiment score of 1.0 on InfoTrie's scale. They also assigned media headlines about the medical technology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Stryker.

Are investors shorting Stryker?

Stryker saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 4,780,000 shares, an increase of 38.6% from the August 30th total of 3,450,000 shares. Based on an average daily volume of 1,060,000 shares, the days-to-cover ratio is currently 4.5 days. Approximately 1.4% of the company's stock are short sold. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), Abbott Laboratories (ABT), Home Depot (HD), CVS Health (CVS), Walt Disney (DIS), AbbVie (ABBV), Bank of America (BAC), General Electric (ge) and Medtronic (MDT).

Who are Stryker's key executives?

Stryker's management team includes the folowing people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include CIBC Private Wealth Group LLC (0.22%), Welch & Forbes LLC (0.14%), Confluence Investment Management LLC (0.08%), Commerzbank Aktiengesellschaft FI (0.06%), LGT Capital Partners LTD. (0.06%) and Chesley Taft & Associates LLC (0.04%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Ferguson Wellman Capital Management Inc., Gateway Investment Advisers LLC, CIBC Private Wealth Group LLC, Welch & Forbes LLC, Stonebridge Capital Management Inc., Suncoast Equity Management, Chesley Taft & Associates LLC and Confluence Investment Management LLC. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

Which institutional investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, State of Alaska Department of Revenue, LGT Capital Partners LTD., Meeder Asset Management Inc., Abner Herrman & Brock LLC, Pacer Advisors Inc., Enlightenment Research LLC and NuWave Investment Management LLC. View Insider Buying and Selling for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $216.19.

How big of a company is Stryker?

Stryker has a market capitalization of $80.88 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

What is Stryker's official website?

The official website for Stryker is http://www.strykercorp.com/.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]


MarketBeat Community Rating for Stryker (NYSE SYK)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  720 (Vote Outperform)
Underperform Votes:  703 (Vote Underperform)
Total Votes:  1,423
MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel